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Summary. Thrombospondin-1 (TSP-1) is a 450 kDa 
matrix bound glycoprotein involved in tumor invasion, 
metastasis, and angiogenesis. One of the receptors 
involved in TSP-1 mediated tumor cell adhesion and 
metastasis is the cysteine-serine-valine-threonine- 
cysteine-glycine (CSVTCG) receptor. One mechanism 
of TSP-1 in promoting tumor cell metastasis involves the 
up-regulation of matrix metalloproteinase-9 (MMP-9) 
expression, specifically through the CSVTCG TSP-1 
receptor. TSP-1 and its CSVTCG receptor has been 
implicated in tumor progression in a variety of cancers 
including breast adenocarcinomas, head and neck 
squamous cell carcinomas, and pancreatic carcinomas. 
In this study, we examined 99 cases of colorectal 
cancer by immunohistochemical analysis to investigate 
1 )  the localization of TSP-1 and CSVTCG TSP-1 
receptor, 2) the relationship with MMP-9, and 3) the 
correlation of expression with clinical staging. 
Strong expression of TSP-1 was observed in the 
submucosa or the serosa adjacent to the tumor. Positive 
staining for CSVTCG TSP-1 receptor was observed in 
tumor cells and microvessels.  MMP-9 was also 
expressed in tumor cells. In addition, staining intensity 
of CSVTCG TSP-1 receptor was higher in poorly 
differentiated adenocarcinoma than well or moderately 
differentiated adenocarcinoma. Tumors in which 
inflammatory cells stained strongly for CSVTCG TSP-1 
receptor correlated with decreased incidence of distant 
metastasis and angiogenesis. 
These data were consistent with our previous studies 
for breast, pancreatic, and head and neck carcinoma. 
They suggest an important role for TSP-1 and CSVTCG 
TSP-1 receptor in tumor progression in colorectal 
cancer. 
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lntroduction 
TSP-1 is a 450kd glycoprotein, originally identified 
as a cornponent of alpha granules of platelets (Lawler et 
al., 1978). Recent studies have shown various cells 
including endothelial cells (McPherson et al., 1981; 
Mosher et al., 1982), smooth muscle cells (Raugi et al., 
1982), fibroblasts (Raugi et al., 1982; Jaffe et al., 1983), 
pneumocytes (Sage et al., 1983), macrophages (Jaffe et 
al., 1985), monocytes (Jaffe et al., 1985), and tumor cells 
(Riser et al., 1988; Varani et al., 1989; Mosher, 1990) 
secrete and synthesize TSP-1.  While numerous 
investigators report TSP-1 inhibits tumor progression 
with its anti angiogenic character, our laboratory and 
severa1 other groups have shown TSP-1 promotes tumor 
cell invasion and angiogenesis. TSP-1 promotes tumor 
cell adhesion, migration in breast cancer cells (Wang et 
al., 1996a), and stimulates bovine aortic endothelial cell 
tube formation in vitro (Qian et al., 1997). TSP-1 also 
increased lung metastasis of B16F10 cells in murine 
model (Tuszynski et al., 1992a). 
CSVTCG specific TSP-1 receptor is a tumor cell 
adhesion receptor, isolated from the total cell extract of a 
lung carcinoma cell line (Tuszynski et al., 1993). This 
receptor mediates the actions of TSP-1 which are 
mentioned above, since tumor cell invasion (Wang et al., 
1996b) was blocked by anti-CSVTCG TSP-1 receptor 
antibody. CSVTCG peptide as well as anti-CSVTCG 
TSP-1 receptor antibody remarkably reduced TSP-1 
stimulated lung metastasis in the B16F10 melanoma cell 
model (Tuszynski et al., 1992a). 
Furthermore, we discovered TSP-1 upregulates 
MMP-9 expression in breast cancer cells and endothelial 
cells (Qian et al., 1997). MMP-9 belongs to a family of 
zinc containing enzymes strongly implicated in tumor 






